These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15009476)
21. The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy. Pierce GF; Lusher JM; Brownstein AP; Goldsmith JC; Kessler CM JAMA; 1989 Jun; 261(23):3434-8. PubMed ID: 2498537 [TBL] [Abstract][Full Text] [Related]
22. Proper donor screening--a good prevention of transfusion transmitted AIDS and hepatitis. Chatterjee K J Acad Hosp Adm; 1994 Jul; 6(2):49-52. PubMed ID: 10537998 [No Abstract] [Full Text] [Related]
23. [Treatment of hemophilia in children]. Stucchi C; Giovanniello A; Dozzi M; Careddu P; Carnelli V Pediatr Med Chir; 1989; 11(6):607-15. PubMed ID: 2517639 [TBL] [Abstract][Full Text] [Related]
24. Transfusion-associated hepatitis and AIDS. What is the risk? Bove JR N Engl J Med; 1987 Jul; 317(4):242-5. PubMed ID: 3110619 [TBL] [Abstract][Full Text] [Related]
25. Blood transfusion--a potential source of HIV/AIDS spread. Mujeeb SA J Pak Med Assoc; 1993 Jan; 43(1):1. PubMed ID: 8474211 [No Abstract] [Full Text] [Related]
26. [Infection hazard due to blood or blood components]. Frenzel H; Lefèvre H Dtsch Med Wochenschr; 1993 Sep; 118(37):1341; author reply 1344. PubMed ID: 8375311 [No Abstract] [Full Text] [Related]
27. AIDS--again. Gracie JA; Lowe GD; Forbes CD Scott Med J; 1985 Jul; 30(3):139-42. PubMed ID: 2997913 [No Abstract] [Full Text] [Related]
28. [Professional risk of viral infections (hepatitis A, B, C and AIDS)]. Gérard C; Sondag D Rev Med Liege; 1996 May; 51(5):341-7. PubMed ID: 8992555 [No Abstract] [Full Text] [Related]
29. Health hazards in forensic science: AIDS and hepatitis. J Forensic Sci Soc; 1986; 26(5):363-7. PubMed ID: 3783122 [No Abstract] [Full Text] [Related]
31. [Transmission of viral infections during transfusion of blood and its components]. Agranenko VA; Krizhevskaia IuV Gematol Transfuziol; 1991 Jun; 36(6):25-7. PubMed ID: 1663054 [No Abstract] [Full Text] [Related]
32. [Risks of infection caused by blood and blood products with reference to the so-called AIDS scandal]. Kretschmer V Infusionsther Transfusionsmed; 1993 Dec; 20(6):286-90. PubMed ID: 8142734 [No Abstract] [Full Text] [Related]
33. Transmission of hepatitis and AIDS: risks for the anaesthetist and the patient. Trépanier CA Can J Anaesth; 1991 May; 38(4 Pt 2):R98-104. PubMed ID: 2060079 [No Abstract] [Full Text] [Related]
34. [Recommendation for standardized approaches toward blood donors carrying an infection transmissible by blood transfusion]. Chassaigne M; Habibi B Rev Fr Transfus Immunohematol; 1987 Feb; 30(1):67-71. PubMed ID: 3616386 [No Abstract] [Full Text] [Related]
35. Hepatitis, acquired immunodeficiency syndrome, and intercourse during menstruation. Brown DW JAMA; 1990 Jan; 263(4):518. PubMed ID: 2294322 [No Abstract] [Full Text] [Related]
36. Coping With Uncertainty: Roz, Ray, and the AIDS Epidemic. Zylke JW JAMA; 2017 Jan; 317(2):116-117. PubMed ID: 28097338 [No Abstract] [Full Text] [Related]
37. The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice. Bayer WL; Tegtmeier GE; Barbara JA Clin Haematol; 1984 Feb; 13(1):253-69. PubMed ID: 6327132 [No Abstract] [Full Text] [Related]
38. RE: Prevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac children. Al-Mendalawi MD Ann Saudi Med; 2013; 33(1):81. PubMed ID: 23458945 [No Abstract] [Full Text] [Related]
39. US inquiry into HIV in blood products. Rowe PM Lancet; 1994 Sep; 344(8926):876. PubMed ID: 7916410 [No Abstract] [Full Text] [Related]
40. Hepatitis C virus and the treatment of hemophilia in Turkey. Kavakli K; Nişli G; Polat A; Aydinok Y; Ozacar T Transfusion; 1998 Aug; 38(8):798-9. PubMed ID: 9709790 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]